• Profile
Close

Chronic oral anticoagluation and risk of prostate cancer: Evidence of detection bias

International Journal of Cancer Oct 14, 2019

Ward MM - Whether lower rates of diagnosed prostate cancer are attributable to a reluctance to perform prostate biopsies in men who are anticoagulated, leading to an apparent protective influence, was investigated in a national population-based sample of elderly men. Between 17,815 men who received chronic oral anticoagulation for prosthetic heart valve thromboprophylaxis and 356,300 men from the general population, the trends in prostate cancer incidence were compared. A substantially lower incidence was found in the anticoagulation group among men registered in 2000-2001 and observed through 2015. Among men enrolled in 2008-2010, a decline in the incidence was reported over time in the general population group to approach that of the anticoagulation group. The researcher concluded that detection bias from lower rates of biopsies among men who are anticoagulated is likely responsible for the apparent protective effect of warfarin treatment on the risk of prostate cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay